Is Koninklijke DSM N.V. a good investment? Koninklijke DSM N.V. (DSM.AS) is currently trading at 114.05 EUR.
For income investors, Koninklijke DSM N.V. pays a dividend yield of 0.82%. With a payout ratio of 73%, the dividend appears sustainable.
Yes, it pays an annual dividend of 0.93 EUR (0.82% yield).
Koninklijke DSM N.V. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.
0.82%
0.93 EUR
Aug. 4, 2022
72.63%
| Year | Total Dividends |
|---|---|
| 2022 | 2.63 EUR |
| Aug. 4, 2022 | 0.9300 |
| May 12, 2022 | 1.7000 |
| 2021 | 2.40 EUR |
| Aug. 5, 2021 | 0.8000 |
| May 10, 2021 | 1.6000 |
| 2020 | 2.43 EUR |
| Aug. 28, 2020 | 0.8000 |
| June 3, 2020 | 1.6300 |
| 2019 | 2.30 EUR |
| Aug. 26, 2019 | 0.7700 |
| June 3, 2019 | 1.5300 |
| 2018 | 2.04 EUR |
| Aug. 24, 2018 | 0.7700 |
| June 1, 2018 | 1.2700 |
| 2017 | 1.20 EUR |
| May 26, 2017 | 1.2000 |
| 2016 | 1.65 EUR |
| Aug. 25, 2016 | 0.5500 |
| May 24, 2016 | 1.1000 |
| 2015 | 1.65 EUR |
| Aug. 25, 2015 | 0.5500 |
| May 27, 2015 | 1.1000 |
| 2014 | 1.70 EUR |
| Aug. 27, 2014 | 0.5500 |
| June 3, 2014 | 1.1500 |
| 2013 | 1.52 EUR |
| Aug. 29, 2013 | 0.5000 |
| May 29, 2013 | 1.0200 |
| 2012 | 1.48 EUR |
| Aug. 30, 2012 | 0.4800 |
| June 6, 2012 | 1.0000 |
| 2011 | 1.40 EUR |
| Aug. 26, 2011 | 0.4500 |
| May 25, 2011 | 0.9500 |
| 2010 | 1.20 EUR |
| Aug. 27, 2010 | 0.4000 |
| April 30, 2010 | 0.8000 |
| 2009 | 1.20 EUR |
| Aug. 28, 2009 | 0.4000 |
| April 21, 2009 | 0.8000 |
| 2008 | 1.27 EUR |
| Aug. 22, 2008 | 0.4000 |
| April 24, 2008 | 0.8700 |
| 2007 | 2.25 EUR |
| Aug. 22, 2007 | 0.3300 |
| May 10, 2007 | 1.2500 |
| April 27, 2007 | 0.6700 |
| 2006 | 1.64 EUR |
| Aug. 11, 2006 | 0.3300 |
| May 12, 2006 | 0.6000 |
| April 13, 2006 | 0.7100 |
| 2005 | 1.75 EUR |
| Aug. 11, 2005 | 0.5800 |
| April 22, 2005 | 1.1700 |
| 2004 | 1.75 EUR |
| Aug. 10, 2004 | 0.5800 |
| April 14, 2004 | 1.1700 |
| 2003 | 1.75 EUR |
| Aug. 11, 2003 | 0.5800 |
| April 17, 2003 | 1.1700 |
| 2002 | 1.86 EUR |
| Aug. 6, 2002 | 0.5800 |
| May 24, 2002 | 0.1100 |
| April 10, 2002 | 1.1700 |
| 2001 | 1.82 EUR |
| Aug. 8, 2001 | 0.5800 |
| April 11, 2001 | 1.2400 |
| 2000 | 1.52 EUR |
| Aug. 15, 2000 | 0.5100 |
| April 12, 2000 | 1.0100 |
Yearly aggregated dividends
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion